Key Highlights

  • NewGenIvf Group (NASDAQ:NIVF) traded at USD 0.5121, down 26.05%, in trading on November 5, 2026, per published market data.
  • A 1-for-8 reverse split of Class A ordinary shares took effect on October 23, 2026, according to a Nasdaq corporate actions alert with a new CUSIP of G0544E162.
  • An earlier 1-for-3 reverse split was set for January 26, 2026, and published coverage counts four reverse splits during 2026.
  • Published coverage says a USD 1.25 million offering at USD 0.07 per share was announced September 29, 2026, a figure treated as single-source.

The Reverse Split Behind the Price

NewGenIvf Group Limited (NASDAQ:NIVF) completed a 1-for-8 reverse split of its Class A ordinary shares effective Friday, October 23, 2026, according to a Nasdaq corporate actions alert that also assigned a new CUSIP number, G0544E162. A reverse split cuts the share count and raises the quoted price by the same factor, without changing the company's market value. It is commonly used to regain the USD 1 minimum bid that Nasdaq requires. Earlier, the company announced a 1-for-3 reverse split effective January 26, 2026, and published coverage counts four splits in 2026. In trading on November 5, 2026, per published market data, the shares were quoted at USD 0.5121, down 26.05%, on Volume of about 86,140 shares. Published coverage put the November 4 close near USD 0.69, so the move is consistent with a continued slide from that level.

Dilution and Financing Pattern

Published coverage describes heavy dilution before the latest split. It reports that the company announced on September 29, 2026 an offering of roughly 17.86 million shares or pre-funded warrants at USD 0.07 per share, for expected gross proceeds of about USD 1.25 million, with Aegis Capital as Placement agent. Proceeds were described as supporting the K25.ai investment, Debt restructuring, Nodexus machine Manufacturing and general working capital. That detail comes from published coverage rather than a filing read here, so treat it as unconfirmed. The same coverage mentions a convertible note exchange in August. When a company repeatedly sells shares at falling prices, each issuance adds supply, pushes the price lower and can trigger another reverse split, a cycle that tends to erode value for existing holders. NewGenIvf operates in fertility services, according to published coverage.

Risks and What to Watch

NewGenIvf is a micro-cap, and a small number of trades can move the price. Spreads can be wide, quoted moves can reverse, and nothing about the 26.05% drop implies it will continue or recover. Published market data show a Market Value near USD 633,000, while other pages show different figures, so the size of the company is itself uncertain. The same data carry an Earnings Per Share figure above 10,000 and a price-to-earnings ratio of 0.00, values that are impossible for this Business and are discarded. Repeated reverse splits and sub-dollar pricing raise the odds of listing compliance problems, although no specific Nasdaq deadline was verified here. Investors should watch filings on new offerings, any Nasdaq notices, the next half-year results and whether the share price holds above USD 1 after the split.

Where Things Stand

NewGenIvf Group (NASDAQ:NIVF) fell 26.05% most plausibly because a reverse split does not fix the underlying dilution cycle, and the price kept sliding from about USD 0.69 to USD 0.5121. A 1-for-8 split lifts the quote mechanically but leaves value unchanged, and the financing pattern in published coverage points to continued share issuance. The balance of evidence is negative to cautious for holders, with little verified fundamental news to offset it. The next catalysts are new offering filings, Nasdaq listing correspondence and any reported results.